Cellares
Industrializing cell therapy manufacturing.
South San Francisco, United States · Founded 2019 · $612.0M raised
- Headquarters
- South San Francisco, California
- Employees
- 51–200
- Founded
- 2019
- Business Model
- B2B
- Website
- cellares.com
- Total Funding
- $612.0M
- Last Round
- $257.0M Series DJan 2026
- Rounds
- 4
About
Cellares is the first Integrated Development and Manufacturing Organization (IDMO) for cell therapies, taking an Industry 4.0 approach to mass manufacturing living drugs. The company develops and operates the Cell Shuttle, a fully automated and scalable cell therapy manufacturing platform, serving biotech and pharmaceutical partners.
Summary
Cellares is a Biotech company based in South San Francisco, United States, founded in 2019. It has raised $612.0M in total across 4 rounds, most recently a $257.0M Series D round in Jan 2026.
Tech & App Stack
8 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2026
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...